CTLA-4(+) Regulatory T Cells Increased in Cetuximab Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis

Podobne knjige/članki

• CD137 stimulation enhances cetuximab induced natural killer (NK): dendritic cell (DC) priming of anti-tumor T cell immunity in head and neck cancer patients
  od: Srivastava, Raghvendra M., et al.
  Izdano: (2016)
• STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients
  od: Srivastava, Raghvendra M, et al.
  Izdano: (2013)
• Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells
  od: López-Albaitero, Andrés, et al.
  Izdano: (2009)
• Cetuximab-activated natural killer (NK) and dendritic cells (DC) collaborate to trigger tumor antigen-specific T cell immunity in head and neck cancer patients
  od: Srivastava, Raghvendra M., et al.
  Izdano: (2013)
• Increased PD-1(+) and TIM-3(+) TILs during cetuximab therapy inversely correlates with response in head and neck cancer patients
  od: Jie, Hyun-Bae, et al.
  Izdano: (2017)